Does Oklahoma Medicaid Cover Wegovy? SoonerCare's GLP-1 Rules for 2026

Not for weight loss. As of November 2026, SoonerCare, Oklahoma’s Medicaid program, treats drugs used only for chronic weight management as a coverage exclusion, but it pays for Wegovy to lower heart risk or treat the liver disease MASH, and for Zepbound to treat sleep apnea, with prior authorization.^[2] All three routes are closed to anyone who has type 1 or type 2 diabetes, and the heart and sleep apnea routes also require an A1c under 6.5%.^[1]

Does SoonerCare cover Wegovy for weight loss?

No. In its August 2026 review, the state said medicines whose only FDA use is chronic weight management, such as Saxenda, are a coverage exclusion, and that drugs used mainly to treat obesity are not covered.^[2] That shuts out orlistat as well, which had no SoonerCare claims in fiscal 2025.^[2] Federal law gives every state this option.^[9] Our explainer on why Medicaid covers Ozempic but not Wegovy for weight sets out the federal rule, and the Medicaid coverage hub compares programs.

The three label uses are a small program. During fiscal 2025, 150 SoonerCare members had paid claims for Wegovy or Zepbound, 390 claims in all.^[2] The SoonerSelect health plans (Aetna Better Health of Oklahoma, Humana Healthy Horizons and Oklahoma Complete Health) follow the state’s clinical criteria for drugs that need review, so the rules below apply whichever plan a member has.^[6]

When will Oklahoma Medicaid pay for Wegovy or Zepbound?

The no-diabetes rule is the detail that trips people up. It appears in every route, and renewals ask again whether the member has developed diabetes.^[1] Someone with type 2 diabetes goes through the diabetes drug list instead, described below.

What does SoonerCare require for Wegovy and heart disease?

The member must be 45 or older with a documented prior heart attack, prior stroke, or leg artery disease with symptoms, shown by claudication with an ankle-brachial index under 0.85, an artery procedure or an amputation from atherosclerosis.^[1] The BMI must be at least 27, and the A1c under 6.5%.^[1] The member must already be on guideline-directed heart treatment, such as blood pressure, cholesterol or antiplatelet drugs, as shown in pharmacy claims, and the request must include office notes on the diet and exercise plan.^[1]

The age floor goes beyond the label, which covers adults with established heart disease and either obesity or overweight and names no minimum age.^[11] Both the Wegovy injection and the Wegovy pill can be approved on this route; maintenance is 1.7 or 2.4 mg for the injection and 25 mg for the tablet.^[1]

Does Oklahoma Medicaid cover Wegovy for fatty liver disease?

Yes, for noncirrhotic MASH with F2 or F3 fibrosis in adults. The request must include one of three test results: a FibroScan with liver stiffness of at least 8 kPa and a CAP score of at least 280, an ELF score of 9 or more, or a biopsy showing F2 or F3 fibrosis.^[1] The member cannot have another chronic liver disease or diabetes, and a gastroenterologist or hepatologist must prescribe or consult.^[1] The FDA approved this use on an accelerated basis.^[11] Our page on semaglutide for MASH covers the evidence.

Does SoonerCare cover Zepbound for sleep apnea, and is CPAP required?

For adults whose sleep apnea is moderate or severe and who also have obesity, Zepbound is covered, and the criteria set no CPAP trial.^[1] The request needs an AHI of 15 or more from a lab study or a home sleep test, a BMI of at least 30, no central or mixed sleep apnea, no diabetes and an A1c under 6.5%.^[1] That tracks the label closely.^[10] On the current Zepbound request form, only a vial needs a patient-specific reason the member cannot use a pen.^[4]

A member who cannot reach at least 5 mg will not be continued.^[1] Renewal at maintenance, 5 to 15 mg, lasts a year and needs a record of better sleep apnea, such as less daytime sleepiness, a partner reporting less snoring or fewer pauses, or fewer AHI events.^[1] Our guide to Zepbound for sleep apnea covers the trials behind it.

Why does SoonerCare approve one dose at a time?

During the build-up, each dose needs its own prior authorization request.^[1] In March 2026 the review board lengthened each of those approvals from four weeks to eight, after hearing that delays were holding up the titration.^[1] If side effects make a step hard, another eight weeks at that dose can be approved with documentation.^[1] Once the member reaches maintenance, approvals run for a year.^[1] Prescribers should send the next dose request well before the current approval runs out so the pharmacy does not stall a refill.

Does SoonerCare cover Ozempic for diabetes?

Yes, but Ozempic is not first in line. On the state’s diabetes list, Trulicity and brand Victoza are Tier 2, Ozempic and Rybelsus are Tier 3, and Mounjaro needs a special prior authorization.^[5] A Tier 2 drug needs a three-month metformin trial or a reason metformin will not work; Tier 3 needs a three-month trial of a Tier 2 drug in the same class that failed.^[5] Every GLP-1 request at the special level must include the current and goal A1c.^[5] Neighboring Texas Medicaid’s GLP-1 rules make a useful comparison.

How do you request prior authorization or appeal in Oklahoma?

Prescribers use form PHARM-277 for Wegovy and PHARM-316 for Zepbound, both revised August 31, 2026, and fax them to the University of Oklahoma College of Pharmacy’s Pharmacy Management Consultants at 1-800-224-4014; the phone line is 1-800-522-0114, option 4.^[3][4]

A SoonerSelect member appeals to the plan first, by phone or in writing, within 60 days of the denial notice.^[7] If the plan upholds it, form LD-1S requests a state fair hearing, with a 120-day limit counted from the plan’s adverse benefit determination notice.^[8] A denial for a missing A1c, sleep study or FibroScan result is usually fixed by resubmitting; one based on a diabetes diagnosis follows the written criteria.^[1] Our guide to prior authorization and appeals covers what to include.

What are the options if SoonerCare says no?

Paying cash, without the manufacturer card: Lilly’s Zepbound savings terms exclude Medicaid enrollees.^[12] In the prices we track, Novo Nordisk sells most Wegovy pen doses for $349 a month, and Lilly’s self-pay Zepbound costs $299 at the starting dose, $399 at 5 mg and $449 at 7.5 mg and up when each refill comes within 45 days.^[12][13] Our list of the cheapest GLP-1 options without insurance compares them.